Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Nightstar Therapeutics plc (NASDAQ: NITE).

Full DD Report for NITE

You must become a subscriber to view this report.


Recent News from (NASDAQ: NITE)

Nightstar Appoints Strategic Biotechnology Executive Paula Cobb to its Board of Directors
WALTHAM, Mass. and LONDON, United Kingdom, Sept. 13, 2018 (GLOBE NEWSWIRE) --  Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced that the company has appointed strategic biotechnolo...
Source: GlobeNewswire
Date: September, 13 2018 06:05
Goldman Sachs, Tencent Led $450M In Chinese E-Commerce Grocer
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Saturday mornings. Did we miss a notable deal? Let us know in the comments. Chinese produce: Goldman Sachs (GS) Investment Part...
Source: SeekingAlpha
Date: September, 08 2018 09:23
Nightstar Therapeutics: Keep Your Eyes Peeled For September Catalysts
Nightstar Therapeutics (NASDAQ: NITE ) is a clinical-stage biotechnology company focused on the development of gene therapies for the treatment of rare inherited retinal diseases. While the company is still at least 2 to 3 years away from commercializing its lead product candidate, I could s...
Source: SeekingAlpha
Date: August, 27 2018 07:31
Premarket analyst action - healthcare
Cardiovascular Systems (NASDAQ: CSII ) initiated with Buy rating and $45 (18% upside) at Stifel citing valuation and expected return to double-digit growth next year. More news on: Cardiovascular Systems, Inc., Nightstar Therapeutics plc, Wright Medical Group, Inc., Healthcare stocks news,...
Source: SeekingAlpha
Date: August, 22 2018 08:13

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1424.8525.4826.1524.85104,095

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-113,7359,53239.1838Short
2018-12-104,4108,74450.4346Short
2018-12-0735,53340,58787.5477Short
2018-12-0659,213119,08549.7233Short
2018-12-0416,53654,79130.1801Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NITE.


About Nightstar Therapeutics plc (NASDAQ: NITE)

Logo for Nightstar Therapeutics plc (NASDAQ: NITE)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: NITE)

      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: September, 13 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: August, 15 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: August, 13 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: August, 10 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: August, 07 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: July, 27 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: June, 14 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: June, 13 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: June, 06 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: May, 15 2018

       

       


      Daily Technical Chart for (NASDAQ: NITE)

      Daily Technical Chart for (NASDAQ: NITE)


      Stay tuned for daily updates and more on (NASDAQ: NITE)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: NITE)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NITE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NITE and does not buy, sell, or trade any shares of NITE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/